{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:51:54Z","timestamp":1776091914629,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,30]]},"DOI":"10.7759\/cureus.38333","type":"journal-article","created":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T16:34:21Z","timestamp":1682872461000},"source":"Crossref","is-referenced-by-count":1,"title":["Rituximab-Induced Serum Sickness Overlapping With Anaphylaxis: A Case Report"],"prefix":"10.7759","author":[{"given":"Adrien","family":"Cottu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarik","family":"Chaara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weniko","family":"Car\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Vanquaethem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert","family":"Nielly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.06.003","article-title":"The pathophysiology of anaphylaxis","volume":"140","author":"Reber LL","year":"2017","unstructured":"Reber LL, Hernandez JD, Galli SJ. The pathophysiology of anaphylaxis. J Allergy Clin Immunol. 2017, 140:335-348. 10.1016\/j.jaci.2017.06.003","journal-title":"J Allergy Clin Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.06.014","article-title":"Rituximab-induced serum sickness: a systematic review","volume":"45","author":"Karmacharya P","year":"2015","unstructured":"Karmacharya P, Poudel DR, Pathak R, et al.. Rituximab-induced serum sickness: a systematic review. Semin Arthritis Rheum. 2015, 45:334-340. 10.1016\/j.semarthrit.2015.06.014","journal-title":"Semin Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2019.06.009","article-title":"Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: a French nationwide study","volume":"67","author":"Bayer G","year":"2019","unstructured":"Bayer G, Agier MS, Lioger B, et al.. Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: a French nationwide study. Eur J Intern Med. 2019, 67:59-64. 10.1016\/j.ejim.2019.06.009","journal-title":"Eur J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2021.02.006","article-title":"[Rituximab immunomonitoring in autoimmune diseases: a support tool in clinical practice?]","volume":"42","author":"Giraud M","year":"2021","unstructured":"Giraud M, Cath\u00e9bras P, Roblin X, et al.. [Rituximab immunomonitoring in autoimmune diseases: a support tool in clinical practice?]. Rev Med Interne. 2021, 42:384-91. 10.1016\/j.revmed.2021.02.006","journal-title":"Rev Med Interne"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.02.018","article-title":"Hypersensitivity reactions to therapeutic monoclonal antibodies: phenotypes and endotypes","volume":"142","author":"Isabwe GA","year":"2018","unstructured":"Isabwe GA, Garcia Neuer M, de Las Vecillas Sanchez L, Lynch DM, Marquis K, Castells M. Hypersensitivity reactions to therapeutic monoclonal antibodies: phenotypes and endotypes. J Allergy Clin Immunol. 2018, 142:159-170.e2. 10.1016\/j.jaci.2018.02.018","journal-title":"J Allergy Clin Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.06.015","article-title":"Anaphylaxis: clinical patterns, mediator release, and severity","volume":"132","author":"Brown SG","year":"2013","unstructured":"Brown SG, Stone SF, Fatovich DM, et al.. Anaphylaxis: clinical patterns, mediator release, and severity. J Allergy Clin Immunol. 2013, 132:1141-1149.e5. 10.1016\/j.jaci.2013.06.015","journal-title":"J Allergy Clin Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-185X.2011.01645.x","article-title":"Serum sickness and severe angioedema following rituximab therapy in RA","volume":"15","author":"Kumar A","year":"2012","unstructured":"Kumar A, Khamkar K, Gopal H. Serum sickness and severe angioedema following rituximab therapy in RA. Int J Rheum Dis. 2012, 15:e6-e7. 10.1111\/j.1756-185X.2011.01645.x","journal-title":"Int J Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.11406\/rinketsu.57.771","article-title":"Repeated rituximab-induced serum sickness with anaphylaxis","volume":"57","author":"Isoda A","year":"2016","unstructured":"Isoda A, Ishikawa T, Sato N, Miyazawa Y, Matsumoto M, Sawamura M. Repeated rituximab-induced serum sickness with anaphylaxis. Rinsho Ketsueki. 2016, 57:771-773. 10.11406\/rinketsu.57.771","journal-title":"Rinsho Ketsueki"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.24953\/turkjped.2020.05.025","article-title":"Rituximab-induced serum sickness and anaphylaxis in a child with nephrotic syndrome","volume":"62","author":"Bayram MT","year":"2020","unstructured":"Bayram MT, Soylu A, Kavuk\u00e7u S. Rituximab-induced serum sickness and anaphylaxis in a child with nephrotic syndrome. Turk J Pediatr. 2020, 62:884-888. 10.24953\/turkjped.2020.05.025","journal-title":"Turk J Pediatr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2010.n.050","article-title":"Rituximab-induced serum sickness masquerading as septic shock","volume":"10","author":"Rampurwala M","year":"2010","unstructured":"Rampurwala M, Kannan S, Gorusu M. Rituximab-induced serum sickness masquerading as septic shock. Clin Lymphoma Myeloma Leuk. 2010, 10:41. 10.3816\/CLML.2010.n.050","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfx072","article-title":"Rituximab-induced serum sickness in the treatment of idiopathic membranous nephropathy","volume":"11","author":"Cheong J","year":"2018","unstructured":"Cheong J, Ooi K. Rituximab-induced serum sickness in the treatment of idiopathic membranous nephropathy. Clin Kidney J. 2018, 11:51-53. 10.1093\/ckj\/sfx072","journal-title":"Clin Kidney J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.02.015","article-title":"Human IgE-independent systemic anaphylaxis","volume":"137","author":"Finkelman FD","year":"2016","unstructured":"Finkelman FD, Khodoun MV, Strait R. Human IgE-independent systemic anaphylaxis. J Allergy Clin Immunol. 2016, 137:1674-1680. 10.1016\/j.jaci.2016.02.015","journal-title":"J Allergy Clin Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2004.11.007","article-title":"Immune complex-mediated tissue injury: a multistep paradigm","volume":"26","author":"Jancar S","year":"2005","unstructured":"Jancar S, S\u00e1nchez Crespo M. Immune complex-mediated tissue injury: a multistep paradigm. Trends Immunol. 2005, 26:48-55. 10.1016\/j.it.2004.11.007","journal-title":"Trends Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/149906-rituximab-induced-serum-sickness-overlapping-with-anaphylaxis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:11Z","timestamp":1707508631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/149906-rituximab-induced-serum-sickness-overlapping-with-anaphylaxis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,30]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.38333","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,30]]}}}